The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1141
October 14, 2002
View Complete Issue         Table of Contents 2019 
Beta Interferons for Multiple Sclerosis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Beta Interferons for Multiple Sclerosis
October 14, 2002 (Issue: 1141)
Three beta interferons are widely used in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Beta Interferons for Multiple Sclerosis
Article code: 1141b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.